Startup Beats $460M Cancer Trade Secrets Case In Delaware

By Andrew Karpan · November 4, 2024, 9:22 PM EST

In front of a federal jury in Delaware, a California biotech startup has defeated a nearly $460 million trade secrets case from a rival that claimed the startup's co-founder helped himself...

To view the full article, register now.

Documents

Case Information

Case Title

I-Mab Biopharma v. Inhibrx, Inc. et al

Case Number

1:22-cv-00276

Court

Delaware

Nature of Suit

Defend Trade Secrets Act (of 2016)

Date Filed

March 01, 2022